Citations (170)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (31)
Lotte Lindberg, Kasper Brødbæk, Erik G. Hägerström, Jens Bentzen, Bent Kristensen & Bo Zerahn. (2017) Comparison of methods for estimating glomerular filtration rate in head and neck cancer patients treated with cisplatin. Scandinavian Journal of Clinical and Laboratory Investigation 77:4, pages 237-246.
Read now
Read now
Stine E. Nielsen, Kasper Rossing, Georg Hess, Dietmar Zdunek, Berit R. Jensen, Hans-Henrik Parving & Peter Rossing. (2012) The effect of RAAS blockade on markers of renal tubular damage in diabetic nephropathy: u-NGAL, u-KIM1 and u-LFABP. Scandinavian Journal of Clinical and Laboratory Investigation 72:2, pages 137-142.
Read now
Read now
Maria Lajer, Inge Tarnow, Alan D. Michelson, Anders Jorsal, Andrew L. Frelinger, Hans-Henrik Parving, Peter Rossing & Lise Tarnow. (2010) Soluble CD40 ligand is elevated in Type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney function. Platelets 21:7, pages 525-532.
Read now
Read now
Lise Tarnow, Anne Sofie Astrup & Hans‐Henrik Parving. (2005) Elevated Placental Growth Factor (PlGF) Predicts Cardiovascular Morbidity and Mortality in Type 1 Diabetic Patients with Diabetic Nephropathy. Scandinavian Journal of Clinical and Laboratory Investigation 65:sup240, pages 73-79.
Read now
Read now
Michele Mussap & Mario Plebani. (2004) Biochemistry and Clinical Role of Human Cystatin C. Critical Reviews in Clinical Laboratory Sciences 41:5-6, pages 467-550.
Read now
Read now
P. K. Christensen, S. Lund, H.-H. Parving. (2001) The impact of glycaemic control on autoregulation of glomerular filtration rate in patients with non-insulin dependent diabetes. Scandinavian Journal of Clinical and Laboratory Investigation 61:1, pages 43-50.
Read now
Read now
H. P. Hansen, P. Rossing, E. R. Mathiesen, E. E Hommel, U. M. Smidt & H.-H. Parving. (1998) Assessment of glomerular filtration rate in diabetic nephropathy using the plasma clearance of 51Cr-EDTA. Scandinavian Journal of Clinical and Laboratory Investigation 58:5, pages 405-414.
Read now
Read now
Anne Pauline Schroeder, Bent Østergaard Kristensen, Claus Brøckner Nielsen & Erling Bjerregaard Pedersen. (1997) Heart Function in Patients with Chronic Glomerulonephritis and Mildly to Moderately Impaired Renal Function: An Echocardiographic Study. Blood Pressure 6:5, pages 286-293.
Read now
Read now
E. B. Pedersen, J. N. Bech, C. B. Nielsen, H. J. Kornerup, H. E. Hansen, E. S. Spencer, J. Sølling & K. T. Jensen. (1997) A comparison of the effect of ramipril, felodipine and placebo on glomerular filtration rate, albuminuria, blood pressure and vasoactive hormones in chronic glomerulonephritis A randomized, prospective, double-blind, placebo-controlled study over two years. Scandinavian Journal of Clinical and Laboratory Investigation 57:8, pages 673-681.
Read now
Read now
Barbro Spångberg-Viklund, Jan Berglund, Tomas Nikonoff, Per Nyberg, Tommy Skau & Rutger Larsson. (1996) Does Prophylactic Treatment with Felodipine, a Calcium Antagonist, Prevent Low-Osmolar Contrast-Induced Renal Dysfunction in Hydrated Diabetic and Nondiabetic Patients with Normal or Moderately Reduced Renal Function?. Scandinavian Journal of Urology and Nephrology 30:1, pages 63-68.
Read now
Read now
H. P. Hansen, K. Rossing, P. Jacobsen, B. R. Jensen & H.-H. Parving. (1996) The acute effect of smoking on systemic haemodynamics, kidney and endothelial functions in insulin-dependent diabetic patients with microalbuminuria. Scandinavian Journal of Clinical and Laboratory Investigation 56:5, pages 393-399.
Read now
Read now
A. Arvidsson & A. Hedman. (1990) Plasma and renal clearance of iohexol–a study on the reproducibility of a method for the glomerular filtration rate. Scandinavian Journal of Clinical and Laboratory Investigation 50:7, pages 757-761.
Read now
Read now
Wiking Månsson, Göran Ahlgren & Thomas White. (1989) Glomerular Filtration Rate up to 10 Years After Urinary Diversion of Different Types. Scandinavian Journal of Urology and Nephrology 23:3, pages 195-200.
Read now
Read now
S. Groth & M. Aasted. (1989) Determination of 51Cr-EDTA Clearance Between 15 and 40 Ml/Min/1.73 M2 by a Single Plasma Sample. Scandinavian Journal of Clinical and Laboratory Investigation 49:8, pages 711-717.
Read now
Read now
S. Groth, M. Aasted & B. Vestergaard. (1989) Screening of Kidney Function by Plasma Creatinine and Single-Sample 51Cr-EDTA Clearance Determination–A Comparison. Scandinavian Journal of Clinical and Laboratory Investigation 49:8, pages 707-710.
Read now
Read now
B. A. Jacobsen, B. N. Jensen, P. B. Mortensen & L. C. Borris. (1989) Parenteral nutrition including amino acids fails to increase creatinine clearance in catabolic patients. Scandinavian Journal of Clinical and Laboratory Investigation 49:5, pages 427-430.
Read now
Read now
Marianne Boijsen, L. Jacobsson & U. Tylén. (1987) Renal Function Measured by X-Ray Fluorescence Analysis. Acta Radiologica 28:5, pages 581-585.
Read now
Read now
G. Daugaard, S. Strandgaard, N.-H. Holstein-Rathlou, P. L. Frederiksen, U. G. Svendsen, O. Munck & P. P. Leyssac. (1987) The renal handling of sodium and water is not affected by the standard-dose Cisplatin treatment for testicular cancer. Scandinavian Journal of Clinical and Laboratory Investigation 47:5, pages 455-459.
Read now
Read now
H. O. Fadnes, J. F. Pape & J. A. Sundsfjord. (1986) A study on oedema mechanism in nephrotic syndrome. Scandinavian Journal of Clinical and Laboratory Investigation 46:6, pages 533-538.
Read now
Read now
J. Brøchner-Mortensen. (1982) The extracellular fluid volume in normal man determined as the distribution volume of [51Cr] EDTA. Scandinavian Journal of Clinical and Laboratory Investigation 42:3, pages 261-264.
Read now
Read now
Göran Granerus & Mattias Aurell. (1981) Reference values for 51Cr-EDTA clearance as a measure of glomerular filtration rate. Scandinavian Journal of Clinical and Laboratory Investigation 41:6, pages 611-616.
Read now
Read now
Birger Trollfors. (1980) Quantitative Studies on Antibiotic Nephrotoxicity. Scandinavian Journal of Infectious Diseases 12:sup21, pages 1-46.
Read now
Read now
Svein Haugstvedt, Jan Bjure & Göran Granerus. (1980) A Simple Method of Background Subtraction in Two-Detector Renography. Scandinavian Journal of Urology and Nephrology 14:3, pages 257-261.
Read now
Read now
U. G. Svendsen, O. Munck, A. Czartoryski & G. Stafanger. (1978) [51Cr] EDTA plasma clearance and endogenous creatinine clearance in advanced renal insufficiency. Scandinavian Journal of Clinical and Laboratory Investigation 38:8, pages 777-779.
Read now
Read now
J. Brøchner-Mortensen, S. Jensen & P. Rødbro. (1977) Assessment of Renal Function from Plasma Creatinine in Adult Patients. Scandinavian Journal of Urology and Nephrology 11:3, pages 263-270.
Read now
Read now
J. Brøchner-Mortensen, S. Jensen & P. Rødbro. (1977) Delimitation of Plasma Creatinine Concentration Values for Assessment of Relative Renal Function in Adult Patients. Scandinavian Journal of Urology and Nephrology 11:3, pages 257-262.
Read now
Read now
P. Mogensen, O. Munck, K. H. Tennesen & H. Wolf. (1977) Compensatory Renal Hypertrophia in Patients Undergoing Unilateral Nephrectomy. Scandinavian Journal of Urology and Nephrology 11:2, pages 155-157.
Read now
Read now
J. Brøchner-Mortensen, K. Rohbrandt & R. B. Lauritzen. (1977) Precision of single injection [51Cr]EDTA plasma clearance and endogenous creatinine clearance determinations in children. Scandinavian Journal of Clinical and Laboratory Investigation 37:7, pages 625-629.
Read now
Read now
J. Bröchner-Mortensen & P. Rödbro. (1976) Optimum Time of Blood Sampling for Determination of Glomerular Filtration Rate by Single-Injection [51Cr]EDTA Plasma Clearance. Scandinavian Journal of Clinical and Laboratory Investigation 36:8, pages 795-800.
Read now
Read now
J. Bröchner-mortensen, L. Tougaard, C. Fynboe & H. Grönlund Thomsen. (1976) Individual Determination of Glomerular Filtration Rate from Plasma Creatinine. Scandinavian Journal of Clinical and Laboratory Investigation 36:4, pages 389-393.
Read now
Read now
J. Bröchner-mortensen & P. Rödbro. (1976) Comparison between Total and Renal Plasma Clearance of [51Cr]EDTA. Scandinavian Journal of Clinical and Laboratory Investigation 36:3, pages 247-249.
Read now
Read now
Articles from other publishers (139)
Nuno Grilo & Brigitte Schurch. 2023. Handbook of Neurourology. Handbook of Neurourology
229
232
.
James Warwick & Jennifer Holness. (2022) Measurement of Glomerular Filtration Rate. Seminars in Nuclear Medicine 52:4, pages 453-466.
Crossref
Crossref
Daniel Christiadi, Charles Simpson, Kate O’brien, Kylie Taylor, Grant Luxton, Monica Rossleigh, Jonathan Erlich & Zoltán H Endre. (2022) Cystatin C kidney functional reserve: a simple method to predict outcome in chronic kidney disease. Nephrology Dialysis Transplantation 37:6, pages 1118-1124.
Crossref
Crossref
Nuno Grilo & Brigitte Schurch. 2022. Handbook of Neurourology. Handbook of Neurourology
1
4
.
Bianca D. Berndorfler, Jennifer L. Holness & James M. Warwick. (2020) Repeatability of glomerular filtration rate studies performed using 99mTc-DTPA in a population including cancer patients. Nuclear Medicine Communications 42:3, pages 261-266.
Crossref
Crossref
Mads Hornum, Luit Penninga, Andreas A Rostved, Karl B Christensen, Peter Oturai, Ulla Plagborg, Bo Feldt-Rasmussen, Jens G Hillingsø & Allan Rasmussen. (2020) Rapid decline in 51Cr-ethylenediaminetetraacetic acid-measured renal function during the first weeks following liver transplantation. Nephrology Dialysis Transplantation 35:3, pages 519-526.
Crossref
Crossref
Pierre Delanaye, Christine A. White, Natalie Ebert & Andrew D. Rule. 2020. Chronic Renal Disease. Chronic Renal Disease
37
54
.
Andrew T. Taylor. 2020. Clinical Nuclear Medicine. Clinical Nuclear Medicine
323
355
.
Signe A. Winther, Jens C. Øllgaard, Nete Tofte, Lise Tarnow, Zeneng Wang, Tarunveer S. Ahluwalia, Anders Jorsal, Simone Theilade, Hans-Henrik Parving, Tine W. Hansen, Stanley L. Hazen, Oluf Pedersen & Peter Rossing. (2019) Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes. Diabetes Care 42:8, pages 1512-1520.
Crossref
Crossref
Ceri Rowe, Alice J. Sitch, Jonathan Barratt, Elizabeth A. Brettell, Paul Cockwell, R. Neil Dalton, Jon J. Deeks, Gillian Eaglestone, Tracy Pellatt-Higgins, Philip A. Kalra, Kamlesh Khunti, Fiona C. Loud, Frances S. Morris, Ryan S. Ottridge, Paul E. Stevens, Claire C. Sharpe, Andrew J. Sutton, Maarten W. Taal & Edmund J. Lamb. (2019) Biological variation of measured and estimated glomerular filtration rate in patients with chronic kidney disease. Kidney International 96:2, pages 429-435.
Crossref
Crossref
Jennifer L. Holness, John S. Fleming, Maxwell T. Chirehwa & James M. Warwick. (2019) Propagation of measurement errors in glomerular filtration rate determination. Nuclear Medicine Communications 40:4, pages 333-342.
Crossref
Crossref
Esteban Porrini, Piero Ruggenenti, Sergio Luis-Lima, Fabiola Carrara, Alejandro Jiménez, Aiko P. J. de Vries, Armando Torres, Flavio Gaspari & Giuseppe Remuzzi. (2018) Estimated GFR: time for a critical appraisal. Nature Reviews Nephrology 15:3, pages 177-190.
Crossref
Crossref
Nuno Grilo & Brigitte Schurch. 2019. Neurourology. Neurourology
195
198
.
Michaela C Devries, Arjun Sithamparapillai, K Scott Brimble, Laura Banfield, Robert W Morton & Stuart M Phillips. (2018) 'Changes in Kidney Function Do Not Differ between Healthy Adults Consuming Higher- Compared with Lower- or Normal-Protein Diets: A Systematic Review and Meta-Analysis. The Journal of Nutrition 148:11, pages 1760-1775.
Crossref
Crossref
S. Pilemann-Lyberg, M. Lindhardt, Frederik Persson, S. Andersen & P. Rossing. (2018) Serum uric acid and progression of diabetic nephropathy in type 1 diabetes. Journal of Diabetes and its Complications 32:5, pages 470-473.
Crossref
Crossref
Peter Rossing, Frederik Persson & Marie Frimodt-Møller. (2018) Prognosis and treatment of diabetic nephropathy: Recent advances and perspectives. Néphrologie & Thérapeutique 14, pages S31-S37.
Crossref
Crossref
Julie Galsgaard, Frederik Persson, Tine Willum Hansen, Anders Jorsal, Lise Tarnow, Hans-Henrik Parving & Peter Rossing. (2017) Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy. Kidney International 92:5, pages 1242-1248.
Crossref
Crossref
C. Joergensen, L. Tarnow, J. P. Goetze & P. Rossing. (2015) Vitamin D analogue therapy, cardiovascular risk and kidney function in people with Type 1 diabetes mellitus and diabetic nephropathy: a randomized trial. Diabetic Medicine 32:3, pages 374-381.
Crossref
Crossref
Pierre Delanaye & Andrew D. Rule. 2015. Chronic Renal Disease. Chronic Renal Disease
31
42
.
Edmund J Lamb, Elizabeth A Brettell, Paul Cockwell, Neil Dalton, Jon J Deeks, Kevin Harris, Tracy Higgins, Philip A Kalra, Kamlesh Khunti, Fiona Loud, Ryan S Ottridge, Claire C Sharpe, Alice J Sitch, Paul E Stevens, Andrew J Sutton & Maarten W Taal. (2014) The eGFR-C study: accuracy of glomerular filtration rate (GFR) estimation using creatinine and cystatin C and albuminuria for monitoring disease progression in patients with stage 3 chronic kidney disease - prospective longitudinal study in a multiethnic population. BMC Nephrology 15:1.
Crossref
Crossref
Jennifer L. Holness, John S. Fleming, Alessandra L. Malaroda & James M. Warwick. (2013) 99mTc-DTPA volume of distribution, half-life and glomerular filtration rate in normal adults. Nuclear Medicine Communications 34:10, pages 1005-1014.
Crossref
Crossref
Stine E Nielsen, Katrine J Schjoedt, Kasper Rossing, Frederik Persson, Casper G Schalkwijk, Coen DA Stehouwer, Hans-Henrik Parving & Peter Rossing. (2012) Levels of NT-proBNP, markers of low-grade inflammation, and endothelial dysfunction during spironolactone treatment in patients with diabetic kidney disease. Journal of the Renin-Angiotensin-Aldosterone System 14:2, pages 161-166.
Crossref
Crossref
Simone Theilade, Maria Lajer, Christel Joergensen, Frederik Persson & Peter Rossing. (2012) Discrepancy Between Tonometric Ambulatory and Cuff‐Based Office Blood Pressure Measurements in Patients With Type 1 Diabetes. The Journal of Clinical Hypertension 14:10, pages 686-693.
Crossref
Crossref
Stine E. Nielsen, Steen Andersen, Dietmar Zdunek, Georg Hess, Hans-Henrik Parving & Peter Rossing. (2011) Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy. Kidney International 79:10, pages 1113-1118.
Crossref
Crossref
Eva Vandermeulen, Carlos De Sadeleer, Amy Piepsz, Hamphrey R. Ham, André A. Dobbeleir, Simon T. Vermeire, Ingrid M. Van Hoek, Sylvie Daminet, Guido Slegers & Kathelijne Y. Peremans. (2010)
Determination of optimal sampling times for a two blood sample clearance method using
51
Cr-EDTA in cats
. Journal of Feline Medicine and Surgery 12:8, pages 577-583.
Crossref
Crossref
Maria LajerAnders JorsalLise TarnowHans-Henrik ParvingPeter Rossing. (2010) Plasma Growth Differentiation Factor-15 Independently Predicts All-Cause and Cardiovascular Mortality As Well As Deterioration of Kidney Function in Type 1 Diabetic Patients With Nephropathy. Diabetes Care 33:7, pages 1567-1572.
Crossref
Crossref
K. J. Schjoedt, P. K. Christensen, A. Jorsal, F. Boomsma, P. Rossing & H.-H. Parving. (2009) Autoregulation of glomerular filtration rate during spironolactone treatment in hypertensive patients with type 1 diabetes: a randomized crossover trial. Nephrology Dialysis Transplantation 24:11, pages 3343-3349.
Crossref
Crossref
C. Maliska, W.R. Pinho, J.E.T. Lima, J. D´Almeida, P.M. Pellegrini & T.S. Schimit. (2009) Taxa de filtração glomerular pelo EDTA marcado com 51cromo e com 113míndio em equinos. Arquivo Brasileiro de Medicina Veterinária e Zootecnia 61:3, pages 547-552.
Crossref
Crossref
Bobby Kalb, John R. Votaw, Puneet Sharma, Khalil Salman, Pegah Ghafourian & Diego R. Martin. (2009) Magnetic Resonance Nephrourographic Techniques and Applications. Topics in Magnetic Resonance Imaging 20:2, pages 59-69.
Crossref
Crossref
Flávia Silva Reis Medeiros, Marcelo T. Sapienza, Elisângela S. Prado, Fabiana Agena, Maria H. M. Shimizu, Francine B. C. Lemos, Carlos A. Buchpiguel, Luiz E. Ianhez & Elias David-Neto. (2009)
Validation of plasma clearance of
51
Cr-EDTA in adult renal transplant recipients: comparison with inulin renal clearance
. Transplant International 22:3, pages 323-331.
Crossref
Crossref
Sanghamitra Chakrabarti & Indrajit Chattopadhyay. (2008) Measuring renal function in old age. Reviews in Clinical Gerontology 18:4, pages 257-267.
Crossref
Crossref
A. Jorsal, L. Tarnow, A. Flyvbjerg, H.-H. Parving, P. Rossing & L. M. Rasmussen. (2008) Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy. Diabetologia 51:11, pages 2100-2107.
Crossref
Crossref
Anders Jorsal, Lise Tarnow, Jan Frystyk, Maria Lajer, Allan Flyvbjerg, Hans-Henrik Parving, Nathalie Vionnet & Peter Rossing. (2008) Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy. Kidney International 74:5, pages 649-654.
Crossref
Crossref
Tri Q. Nguyen, Lise Tarnow, Anders Jorsal, Noelynn Oliver, Peggy Roestenberg, Yasuhiko Ito, Hans-Henrik Parving, Peter Rossing, Frans A. van Nieuwenhoven & Roel Goldschmeding. (2008) Plasma Connective Tissue Growth Factor Is an Independent Predictor of End-Stage Renal Disease and Mortality in Type 1 Diabetic Nephropathy. Diabetes Care 31:6, pages 1177-1182.
Crossref
Crossref
Maria Lajer, Lise Tarnow, Anders Jorsal, Tom Teerlink, Hans-Henrik Parving & Peter Rossing. (2008) Plasma Concentration of Asymmetric Dimethylarginine (ADMA) Predicts Cardiovascular Morbidity and Mortality in Type 1 Diabetic Patients With Diabetic Nephropathy. Diabetes Care 31:4, pages 747-752.
Crossref
Crossref
Iosif Mendichovszky, Michael Pedersen, Jørgen Frøkiær, Thomas Dissing, Nicolas Grenier, Peter Anderson, Kieran McHugh, Qing Yang & Isky Gordon. (2008) How accurate is dynamic contrast-enhanced MRI in the assessment of renal glomerular filtration rate? A critical appraisal. Journal of Magnetic Resonance Imaging 27:4, pages 925-931.
Crossref
Crossref
Anne Sofie Astrup, Flemming S Nielsen, Peter Rossing, Samir Ali, Jens Kastrup, Ulla Meng Smidt & Hans-Henrik Parving. (2007) Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up study. Journal of Hypertension 25:12, pages 2479-2485.
Crossref
Crossref
Won Yong KimAnne Sofie AstrupMatthias StuberLise TarnowErling FalkRené M. BotnarCheryl SimonsenLotte PietraszekPeter R. HansenWarren J. ManningNiels T. AndersenHans-Henrik Parving. (2007) Subclinical Coronary and Aortic Atherosclerosis Detected by Magnetic Resonance Imaging in Type 1 Diabetes With and Without Diabetic Nephropathy. Circulation 115:2, pages 228-235.
Crossref
Crossref
A. T. Taylor. 2007. Clinical Nuclear Medicine. Clinical Nuclear Medicine
172
198
.
A. Piepsz, M. Tondeur & H. Ham. (2006) Revisiting normal 51Cr-ethylenediaminetetraacetic acid clearance values in children. European Journal of Nuclear Medicine and Molecular Imaging 33:12, pages 1477-1482.
Crossref
Crossref
K.J. Schjoedt, K. Rossing, T.R. Juhl, F. Boomsma, L. Tarnow, P. Rossing & H.H. Parving. (2006) Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy. Kidney International 70:3, pages 536-542.
Crossref
Crossref
Peter Rossing, Kasper Rossing, Peter Gæde, Oluf Pedersen & Hans-Henrik Parving. (2006) Monitoring Kidney Function in Type 2 Diabetic Patients With Incipient and Overt Diabetic Nephropathy. Diabetes Care 29:5, pages 1024-1030.
Crossref
Crossref
Anne Sofie Astrup, Lise Tarnow, Peter Rossing, Birgitte V. Hansen, Jannik Hilsted & Hans-Henrik Parving. (2006) Cardiac Autonomic Neuropathy Predicts Cardiovascular Morbidity and Mortality in Type 1 Diabetic Patients With Diabetic Nephropathy. Diabetes Care 29:2, pages 334-339.
Crossref
Crossref
. 2006. Functional Imaging in Nephro-Urology. Functional Imaging in Nephro-Urology
13
20
.
Piyush M. Srivastava, Merlin C. Thomas, Paul Calafiore, Richard J. MacIsaac, George Jerums & Louise M. Burrell. (2005) Diastolic dysfunction is associated with anaemia in patients with Type II diabetes. Clinical Science 110:1, pages 109-116.
Crossref
Crossref
Katrine Jordan Schjoedt, Kasper Rossing, Tina Ragnholm Juhl, Frans Boomsma, Peter Rossing, Lise Tarnow & Hans-Henrik Parving. (2005) Beneficial impact of spironolactone in diabetic nephropathy. Kidney International 68:6, pages 2829-2836.
Crossref
Crossref
K. Rossing, P. K. Christensen, P. Hovind & H.-H. Parving. (2005) Remission of nephrotic-range albuminuria reduces risk of end-stage renal disease and improves survival in type 2 diabetic patients. Diabetologia 48:11, pages 2241-2247.
Crossref
Crossref
Anne Sofie Astrup, Lise Tarnow, Peter Rossing, Lotte Pietraszek, Peter Riis Hansen & Hans-Henrik Parving. (2005) Improved prognosis in type 1 diabetic patients with nephropathy: A prospective follow-up study. Kidney International 68:3, pages 1250-1257.
Crossref
Crossref
Kasper Rossing, Katrine J. Schjoedt, Berit R. Jensen, Frans Boomsma & Hans-Henrik Parving. (2005) Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria. Kidney International 68:3, pages 1190-1198.
Crossref
Crossref
Paul F. Sherwin, Richard Cambron, Judith A. Johnson & Joseph A. Pierro. (2005) Contrast Dose-to-Creatinine Clearance Ratio as a Potential Indicator of Risk for Radiocontrast-Induced Nephropathy. Investigative Radiology 40:9, pages 598-603.
Crossref
Crossref
Steen Andersen, Frans A. van Nieuwenhoven, Lise Tarnow, Peter Rossing, Kasper Rossing, Lotte Wieten, Roel Goldschmeding & Hans-Henrik Parving. (2005) Reduction of urinary connective tissue growth factor by Losartan in type 1 patients with diabetic nephropathy. Kidney International 67:6, pages 2325-2329.
Crossref
Crossref
L. Tarnow, P. Hildebrandt, B. V. Hansen, K. Borch-Johnsen & H.-H. Parving. (2004) Plasma N-terminal pro-brain natriuretic peptide as an independent predictor of mortality in diabetic nephropathy. Diabetologia 48:1, pages 149-155.
Crossref
Crossref
G. Jerums, T. J. Allen, D. J. Campbell, M. E. Cooper, R. E. Gilbert, J. J. Hammond, R. C. O'Brien, J. Raffaele & C. Tsalamandris. (2004) Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria. Diabetic Medicine 21:11, pages 1192-1199.
Crossref
Crossref
Edmund J Lamb, Helen J Stowe, David E Simpson, Anthony J Coakley, David J Newman & Maeve Leahy. (2004) Diagnostic Accuracy of Cystatin C as a Marker of Kidney Disease in Patients with Multiple Myeloma: Calculated Glomerular Filtration Rate Formulas Are Equally Useful. Clinical Chemistry 50:10, pages 1848-1851.
Crossref
Crossref
Kasper Rossing, Per K. Christensen, Peter Hovind, Lise Tarnow, Peter Rossing & Hans-Henrik Parving. (2004) Progression of nephropathy in type 2 diabetic patients. Kidney International 66:4, pages 1596-1605.
Crossref
Crossref
Lise Tarnow, Peter Hovind, Tom Teerlink, Coen D.A. Stehouwer & Hans-Henrik Parving. (2004) Elevated Plasma Asymmetric Dimethylarginine as a Marker of Cardiovascular Morbidity in Early Diabetic Nephropathy in Type 1 Diabetes. Diabetes Care 27:3, pages 765-769.
Crossref
Crossref
Steen Andersen, Jens Bröchner-Mortensen & Hans-Henrik Parving. (2003) Kidney Function During and After Withdrawal of Long-Term Irbesartan Treatment in Patients With Type 2 Diabetes and Microalbuminuria. Diabetes Care 26:12, pages 3296-3302.
Crossref
Crossref
Kasper Rossing, Peter Jacobsen, Lotte Pietraszek & Hans-Henrik Parving. (2003) Renoprotective Effects of Adding Angiotensin II Receptor Blocker to Maximal Recommended Doses of ACE Inhibitor in Diabetic Nephropathy. Diabetes Care 26:8, pages 2268-2274.
Crossref
Crossref
Steen Andersen, Lise Tarnow, Francois Cambien, Peter Rossing, Tina R. Juhl, Jaap Deinum & Hans-Henrik Parving. (2003) Long-Term Renoprotective Effects of Losartan in Diabetic Nephropathy. Diabetes Care 26:5, pages 1501-1506.
Crossref
Crossref
Peter Jacobsen, Steen Andersen, Kasper Rossing, Berit R. Jensen & Hans-Henrik Parving. (2003) Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy. Kidney International 63:5, pages 1874-1880.
Crossref
Crossref
P. Jacobsen, P. Rossing, L. Tarnow, P. Hovind & H-H. Parving. (2003) Birth weight - a risk factor for progression in diabetic nephropathy?. Journal of Internal Medicine 253:3, pages 343-350.
Crossref
Crossref
Per K. Christensen, Kamran Akram, Karen B. Kønig & Hans-Henrik Parving. (2003) Autoregulation of Glomerular Filtration Rate in Patients With Type 2 Diabetes During Isradipine Therapy. Diabetes Care 26:1, pages 156-162.
Crossref
Crossref
Kasper Rossing, Per K. Christensen, Birgitte V. Hansen, Bendix Carstensen & Hans-Henrik Parving. (2003) Optimal Dose of Candesartan for Renoprotection in Type 2 Diabetic Patients With Nephropathy. Diabetes Care 26:1, pages 150-155.
Crossref
Crossref
Henrik P. Hansen, Ellis Tauber-Lassen, Berit R. Jensen & Hans-Henrik Parving. (2002) Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy. Kidney International 62:1, pages 220-228.
Crossref
Crossref
Steen Andersen, Lise Tarnow, Francois Cambien, Peter Rossing, Tina R. Juhl, Jaap Deinum & Hans-Henrik Parving. (2002) Renoprotective effects of losartan in diabetic nephropathy: Interaction with ACE insertion/deletion genotype?. Kidney International 62:1, pages 192-198.
Crossref
Crossref
Inam Haq & D.A. Isenberg. (2002) How does one assess and monitor patients with systemic lupus erythematosus in daily clinical practice?. Best Practice & Research Clinical Rheumatology 16:2, pages 181-194.
Crossref
Crossref
Kasper Rossing, Per K. Christensen, Berit R. Jensen & Hans-Henrik Parving. (2002) Dual Blockade of the Renin-Angiotensin System in Diabetic Nephropathy. Diabetes Care 25:1, pages 95-100.
Crossref
Crossref
Henrik P. Hansen, Peter Hovind, Berit R. Jensen & Hans-Henrik Parving. (2002) Diurnal variations of glomerular filtration rate and albuminuria in diabetic nephropathy. Kidney International 61:1, pages 163-168.
Crossref
Crossref
Per Knud Christensen, Svend Larsen, Thomas Horn, Steen Olsen & Hans‐Henrik Parving. (2001) Renal function and structure in albuminuric type 2 diabetic patients without retinopathy. Nephrology Dialysis Transplantation 16:12, pages 2337-2347.
Crossref
Crossref
Per K. Christensen, Søren Lund & Hans-Henrik Parving. (2001) Autoregulated glomerular filtration rate during candesartan treatment in hypertensive type 2 diabetic patients. Kidney International 60:4, pages 1435-1442.
Crossref
Crossref
Steen Andersen, Lise Tarnow, Peter Rossing, Birgitte V. Hansen & Hans-Henrik Parving. (2000) Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy. Kidney International 57:2, pages 601-606.
Crossref
Crossref
Per K. Christensen, Svend Larsen, Thomas Horn, Steen Olsen & Hans-Henrik Parving. (2000) Causes of albuminuria in patients with type 2 diabetes without diabetic retinopathy. Kidney International 58:4, pages 1719-1731.
Crossref
Crossref
Yves Lacourcière, André Bélanger, Chantal Godin, Jean-Pierre Hallé, Stuart Ross, Noël Wright & Jean Marion. (2000) Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy. Kidney International 58:2, pages 762-769.
Crossref
Crossref
E. Fontaine, R. Leaver & C.R.J. Woodhouse. (2001) The effect of intestinal urinary reservoirs on renal function: a 10‐year follow‐up. BJU International 86:3, pages 195-198.
Crossref
Crossref
Peter Hovind, Lise Tarnow, Per B. Oestergaard & Hans-Henrik Parving. (2000) Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy. Kidney International 57, pages S56-S61.
Crossref
Crossref
Steen Andersen, Lise Tarnow, Peter Rossing, Birgitte V. Hansen & Hans-Henrik Parving. (2000) Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy. Kidney International 57:2, pages 601-606.
Crossref
Crossref
P.M. Petersen & S.W. Hansen. (1999) The course of long-term toxicity in patients treated with cisplatin-based chemotherapy for non-seminomatous germ-cell cancer. Annals of Oncology 10:12, pages 1475-1484.
Crossref
Crossref
C. Houlihan, M. Jenkins, T. Osicka, A. Scott, D. Parkin & G. Jerums. (2008) A comparison of the plasma disappearance of iohexol and 99m Tc‐DTPA for the measurement of glomerular filtration rate (GFR) in diabetes. Australian and New Zealand Journal of Medicine 29:5, pages 693-700.
Crossref
Crossref
Per K. Christensen, Eva E. Hommel, Peter Clausen, Bo Feldt-Rasmussen & Hans.-Henrik. Parving. (1999) Impaired autoregulation of the glomerular filtration rate in patients with nondiabetic nephropathies. Kidney International 56:4, pages 1517-1523.
Crossref
Crossref
Carles Villabona, Manuel Sahun, Núria Gómez, José M. Gómez, Joan Soler, Manuel Roca, Jaume Mora & Rafael Puchal. (1999) Blood Volumes and Renal Function in Overt and Subclinical Primary Hypothyroidism. The American Journal of the Medical Sciences 318:4, pages 277-280.
Crossref
Crossref
Peter Jacobsen, Kasper Rossing, Lise Tarnow, Peter Rossing, Christine Mallet, Odette Poirier, Francois Cambien & Hans-Henrik Parving. (1999) Progression of diabetic nephropathy in normotensive type 1 diabetic patients. Kidney International 56, pages S101-S105.
Crossref
Crossref
P. K. Christensen, P. Rossing, F. S. Nielsen & H. ‐H. Parving. (2001) Natural course of kidney function in Type 2 diabetic patients with diabetic nephropathy. Diabetic Medicine 16:5, pages 388-394.
Crossref
Crossref
Henrik P. Hansen, Per K. Christensen, Ellis Tauber-Lassen, Annalise Klausen, Berit R. Jensen & Hans-Henrik Parving. (1999) Low-protein diet and kidney function in insulin-dependent diabetic patients with diabetic nephropathy. Kidney International 55:2, pages 621-628.
Crossref
Crossref
Flavio Gaspari, Norberto Perico & Giuseppe Remuzzi. (1998) Application of newer clearance techniques for the determination of glomerular filtration rate. Current Opinion in Nephrology and Hypertension 7:6, pages 675-680.
Crossref
Crossref
Peter Jacobsen, Kasper Rossing, Peter Rossing, Lise Tarnow, Christine Mallet, Odette Poirier, Francois Cambien & Hans-Henrik Parving. (1998) Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathy. Kidney International 53:4, pages 1002-1006.
Crossref
Crossref
B. A. Lwaleed, P. S. Bass, M. E. Rogerson, J. L. Francis & M. Chisholm. (1998) Effect of kidney function and disease status on urinary tissue factor measurements. Journal of Clinical Pathology 51:3, pages 234-237.
Crossref
Crossref
Per K. Christensen, Henrik P. Hansen & Hans-Henrik Parving. (1997) Impaired autoregulation of GFR in hypertensive non-insulin dependent diabetic patients. Kidney International 52:5, pages 1369-1374.
Crossref
Crossref
Dirk Campens & Frank Buntinx. (2009)
Selecting the Best Renal Function Tests:
A Meta-analysis of Diagnostic Studies
. International Journal of Technology Assessment in Health Care 13:2, pages 343-356.
Crossref
Crossref
Henrik P. Hansen, Peter Rossing, Lise Tarnow, Flemming S. Nielsen, Berit R. Jensen & Hans-Henrik Parving. (1996) Circadian rhythm of arterial blood pressure and albuminuria in diabetic nephropathy. Kidney International 50:2, pages 579-585.
Crossref
Crossref
M. J. Millward, L. K. Webster, G. C. Toner, J. F. Bishop, D. Rischin, K. H. Stokes, V. K. Johnston & R. Hicks. (2008) Carboplatin dosing based on measurement of renal function — experience at the Peter MacCallum Cancer Institute. Australian and New Zealand Journal of Medicine 26:3, pages 372-379.
Crossref
Crossref
Amy Piepsz, Marianne Tondeur, Jacques Kinthaert & Hamphrey R. Ham. (1996) Reproducibility of technetium-99m mercaptoacetyltriglycine clearance. European Journal of Nuclear Medicine 23:2, pages 195-198.
Crossref
Crossref
A. KRISTJÁNSSON, L. WALLIN & W. MÅNSSON. (2008) Renal function up to 16 years after conduit (refluxing or anti‐reflux anastomosis) or continent urinary diversion. 1. Glomerular filtration rate and patency of uretero‐intestinal anastomosis. British Journal of Urology 76:5, pages 539-545.
Crossref
Crossref
Henrik P. Hansen, Peter Rossing, Lise Tarnow, Flemming S. Nielsen, Berit R. Jensen & Hans-Henrik Parving. (1995) Increased glomerular filtration rate after withdrawal of long-term antihypertensive treatment in diabetic nephropathy. Kidney International 47:6, pages 1726-1731.
Crossref
Crossref
S.C.W. Brown & P.H. O'Reilly. (2008) Glomerular filtration rate measurement: a neglected test in urological practice. British Journal of Urology 75:3, pages 296-300.
Crossref
Crossref
M. Capek, C. Schnack, B. Ludvik, A. Kautzky-Willer, M. Banyai & R. Prager. (1994) Effects of captopril treatment versus placebo on renal function in type 2 diabetic patients with microalbuminuria: a long-term study. The Clinical Investigator 72:12, pages 961-966.
Crossref
Crossref
R PedrinelliG CatapanoG Dell'OmoE MelilloL TalaricoC Di MuroO GiampietroF CarmassiC GiustiV Di Bello. (1994) Forearm blood flow reserve and cardiac and renal indexes of pressure load in normotensive and hypertensive individuals.. Hypertension 24:1, pages 24-29.
Crossref
Crossref
P. Rossing, A. -S. Astrup, U. M. Smidt & H. -H. Parving. (1994) Monitoring kidney function in diabetic nephropathy. Diabetologia 37:7, pages 708-712.
Crossref
Crossref
L. D. Elving, J. F. M. Wetzels, H. J. J. van Lier, E. de Nobel & J. H. M. Berden. (1994) Captopril and atenolol are equally effective in retarding progression of diabetic nephropathy. Diabetologia 37:6, pages 604-609.
Crossref
Crossref
P. Rossing, E. Hommel, U. M. Smidt & H. -H. Parving. (1994) Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment. Diabetologia 37:5, pages 511-516.
Crossref
Crossref
M.J. Sampson, V.S. Griffith & P.L. Drury. (2009) Blood Pressure, Diet and the Progression of Nephropathy in Patients with Type 1 Diabetes and Hypertension. Diabetic Medicine 11:2, pages 150-154.
Crossref
Crossref
Ch. Schnack, M. Capek, M. Banyai, A. Kautzky-Willer, R. Prager & G. Schernthaner. (1994) Long-term treatment with nifedipine reduces urinary albumin excretion and glomerular filtration rate in normotensive type 1 diabetic patients with microalbuminuria. Acta Diabetologica 31:1, pages 14-18.
Crossref
Crossref
F. Hansen, D. Bergqvist, P. Mangell, Å. Rydén, B. Sonesson & T. Länne. (2008) Non‐invasive measurement of pulsatile vessel diameter change and elastic properties in human arteries: a methodological study,. Clinical Physiology 13:6, pages 631-643.
Crossref
Crossref
J P Vora, A Burch, D R Owens & J R Peters. (1991) Simultaneous determination of glomerular filtration rate and effective renal plasma flow. Clinical Physics and Physiological Measurement 12:3, pages 269-277.
Crossref
Crossref
D G Waller, J S Fleming, B Ramsey & J Gray. (1991) The accuracy of creatinine clearance with and without urine collection as a measure of glomerular filtration rate. Postgraduate Medical Journal 67:783, pages 42-46.
Crossref
Crossref
Rutger Larsson, Bengt E. Karlberg, Agneta Gelin, Jan Åberg & Carl‐Gunnar Regårdh. (2013) Acute and Steady‐State Pharmacokinetics and Antihypertensive Effects of Felodipine in Patients with Normal and Impaired Renal Function. The Journal of Clinical Pharmacology 30:11, pages 1020-1030.
Crossref
Crossref
Principal discussant: Andrew S. Levey. (1990) Measurement of renal function in chronic renal disease. Kidney International 38:1, pages 167-184.
Crossref
Crossref
R. Larsson, M. K. Lindsjö, B. Danielsson, U. Bengtsson, J. H. Hardlund, P. A. Sjöström, D. Elmfeldt & L. Moberg. (1990) Felodipine in the treatment of patients with severe hypertension and impaired renal function. Cardiovascular Drugs and Therapy 4:1, pages 253-259.
Crossref
Crossref
R B Payne. (2016) Biological Variation of Serum and Urine Creatinine and Creatinine Clearance. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 26:6, pages 565-565.
Crossref
Crossref
S. GROTH, C. PETERSEN, A. DIRKSEN & H.‐H. PARVING. (2011) Monitoring kidney function in diabetic nephropathy. Journal of Internal Medicine 226:5, pages 341-343.
Crossref
Crossref
H. -H. Parving, M. Larsen, E. Hommel & H. Lund-Andersen. (1989) Effect of antihypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive Type 1 (insulin-dependent) diabetic patients with background retinopathy. Diabetologia 32:7, pages 440-444.
Crossref
Crossref
E.B. PEDERSEN, S. S. SØRENSEN, A. AMDISEN, H. DANIELSEN, H. EISKJÆR, H. H. HANSEN, F.T. JENSEN, B. JESPERSEN, B. MADSEN & H. K. NIELSEN. (2008) Abnormal glomerular and tubular function during angiotensin converting enzyme inhibition in renovascular hypertension evaluated by the lithium clearance method. European Journal of Clinical Investigation 19:2, pages 135-141.
Crossref
Crossref
S. A. Smith. (1988) Estimation of glomerular filtration rate from the serum creatinine concentration.. Postgraduate Medical Journal 64:749, pages 204-208.
Crossref
Crossref
H H Parving, A R Andersen, U M Smidt, E Hommel, E R Mathiesen & P A Svendsen. (1987) Effect of antihypertensive treatment on kidney function in diabetic nephropathy.. BMJ 294:6585, pages 1443-1447.
Crossref
Crossref
. (2009) REFERENCES. Acta Medica Scandinavica 222:S722, pages 58-69.
Crossref
Crossref
R B Payne. (2016) Creatinine Clearance: A Redundant Clinical Investigation. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 23:3, pages 243-250.
Crossref
Crossref
Keith E. Britton. 1986. Nuclear Techniques in Diagnostic Medicine. Nuclear Techniques in Diagnostic Medicine
333
368
.
J. KASTRUP, P. PETERSEN, R. BARTRAM & J. M. HANSEN. (2008) The Effect of Trimethoprim on Serum Creatinine. British Journal of Urology 57:3, pages 265-268.
Crossref
Crossref
J. Brøchner‐Mortensen. (2008) Current status on assessment and measurement of glomerular filtration rate. Clinical Physiology 5:1, pages 1-17.
Crossref
Crossref
PALLE PETERSEN, JENS KASTRUP, REINHOLD BARTRAM & JENS MØLHOLM HANSEN. (2009) Digoxin–Trimethoprim Interaction. Acta Medica Scandinavica 217:4, pages 423-427.
Crossref
Crossref
K. Levorstad, A. Kolbenstvedt, F. Kolmannskog, S. Chr. Sommerfelt, H. Stormorken, E. Andrew & K. Sveen. (2016) Tolerability of Iohexol after Injection into Healthy Volunteers. Acta Radiologica. Diagnosis 24:3, pages 241-251.
Crossref
Crossref
Ian M. Thompson, Frank G. Boineau, Blackwell B. Evans & Jorgen U. Schlegel. (1983) The Renal Quantitative Scintillation Camera Study for Determination of Renal Function. Journal of Urology 129:3, pages 461-465.
Crossref
Crossref
R. Müller‐Suur, M. Göransson, L. Olsen, G. Bâcklund & L. Bäcklund. (2008) Inulin single injection clearance. Microsample technique useful in children for determination of glomerular filtration rate. Clinical Physiology 3:1, pages 19-27.
Crossref
Crossref
E. B. Pedersen, J. SØLling, C. E. Mogensen & K. D. Christensen. (2009) URINARY EXCRETION OF ALBUMIN AND BETA-2-MICROGLOBULIN, GLOMERULAR FILTRATION RATE AND IMMUNE COMPLEXES IN SERUM DURING INFECTIOUS MONONUCLEOSIS. Acta Pathologica Microbiologica Scandinavica Series C: Immunology 90C:1-6, pages 301-305.
Crossref
Crossref
L. Rao Chervu & M. Donald Blaufox. (1982) Renal radiopharmaceuticals—An update. Seminars in Nuclear Medicine 12:3, pages 224-245.
Crossref
Crossref
JP Kampmann & JM Hansen. (2012) Glomerular filtration rate and creatinine clearance.. British Journal of Clinical Pharmacology 12:1, pages 7-14.
Crossref
Crossref
L. Brauner & H. Westling. (2008)
On the necessity of strict bed rest during determination of
51
Cr‐EDTA clearance
. Clinical Physiology 1:2, pages 175-180.
Crossref
Crossref
Jens H. Henriksen & Niels A. Lassen. (2008) Decreased renal function in cirrhosis–an adaptive response?. Clinical Physiology 1:2, pages 131-138.
Crossref
Crossref
Alf Askergren, Ragnar Brandt, Roger Gullquist, Birgitta Silk & Tore Strandell. (2009) The Effect of Fluid Deprivation, Antidiuretic Hormone and Forced Fluid Intake on 51-Cr-EDTA Clearance. Acta Medica Scandinavica 210:1-6, pages 377-380.
Crossref
Crossref
N. Frimodt-Möller, S. Maigaard & P. O. Madsen. (1980) Comparative nephrotoxicity among aminoglycosides and beta-lactam antibioticsVergleich der Nephrotoxizität von Aminoglycosiden und β-Lactam Antibiotika. Infection 8:6, pages 283-289.
Crossref
Crossref
Susanne Ljungman, Mattias Aurell, Marianne Hartford, John Wikstrand, Lars Wilhelmsen & Goran Berglund. (2009) Blood Pressure and Renal Function. Acta Medica Scandinavica 208:1-6, pages 17-25.
Crossref
Crossref
Abraham P. Provoost & Jan C. Molenaar. (1980) Changes in the glomerular filtration rate after unilateral nephrectomy in rats. Pfl�gers Archiv European Journal of Physiology 385:2, pages 161-165.
Crossref
Crossref
N Frimodt-Möller, S Maigaard & P O Madsen. (1979) Netilmicin treatment of complicated urinary tract infection in patients with renal function impairment. Antimicrobial Agents and Chemotherapy 16:3, pages 406-410.
Crossref
Crossref
Rutger Larsson, Göran Bodemar & Bertil Kågedal. (2009) The Effect of Cimetidine, a New Histamine H2-Receptor Antagonist, on Renal Function. Acta Medica Scandinavica 205:1-6, pages 87-89.
Crossref
Crossref
Claus Christiansen, Paul Rødbro, MereteSanvig Christensen, Birgitte Hartnack & Ib Transbøl. (1978) DETERIORATION OF RENAL FUNCTION DURING TREATMENT OF CHRONIC RENAL FAILURE WITH 1,25- DIHYDROXYCHOLECALCIFEROL. The Lancet 312:8092, pages 700-703.
Crossref
Crossref
D. B. Morgan, S. Dillon & R. B. Payne. (1978) The assessment of glomerular function: creatinine clearance or plasma creatinine?. Postgraduate Medical Journal 54:631, pages 302-310.
Crossref
Crossref
Win L. Chiou, M.A.F. Gadalla & Geoffrey W. Peng. (1978) Simple, Rapid, and Micro High-Pressure Liquid Chromatographic Determination of Endogenous “True” Creatinine in Plasma, Serum, and Urine. Journal of Pharmaceutical Sciences 67:2, pages 182-187.
Crossref
Crossref
B. H. Jensen, P. Berthelsen & J. Bröchner‐Mortensen. (2008) Glomerular Filtration Rate during Halothane Anaesthesia and Epidural Analgesia in Combination with Halothane Anaesthesia. Acta Anaesthesiologica Scandinavica 21:5, pages 395-399.
Crossref
Crossref
Lars Tougaard, Egon Sørensen, Merete Sanvig Christensen, Jens Brøchner-Mortensen, Paul Rødbro & Arne W. S. Sørensen. (2009) Bone Composition and Parathyroid Function in Chronic Renal Failure. Acta Medica Scandinavica 202:1-6, pages 33-38.
Crossref
Crossref
M. S. Christensen, J. Brøchner-Mortensen, L. Tougaard, E. Sørensen & P. Rødbro. 1977. Phosphate Metabolism. Phosphate Metabolism
131
139
.